Cargando…
A large pooled analysis refines gene expression-based molecular subclasses in cutaneous melanoma
This study aimed to establish the number of expression-based molecular subclasses in cutaneous melanoma, identify their dominant biological pathways and evaluate their clinical relevance. To this end, consensus clustering was performed separately on two independent datasets (n = 405 and n = 473) com...
Autores principales: | Wind, Thijs T., Jalving, Mathilde, de Haan, Jacco J., de Vries, Elisabeth G. E., van Vugt, Marcel A. T. M., Reijngoud, Dirk-Jan, van Rijn, Rozemarijn S., Haanen, John B. A. G., Blank, Christian U., Hospers, Geke A. P., Fehrmann, Rudolf S. N. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350693/ https://www.ncbi.nlm.nih.gov/pubmed/30723592 http://dx.doi.org/10.1080/2162402X.2018.1558664 |
Ejemplares similares
-
Value of screening and follow‐up brain MRI scans in patients with metastatic melanoma
por: Eggen, Annemarie C., et al.
Publicado: (2021) -
A Survival Tree of Advanced Melanoma Patients with Brain Metastases Treated with Immune Checkpoint Inhibitors
por: van Not, Olivier J., et al.
Publicado: (2023) -
Interleukin-2 PET imaging in patients with metastatic melanoma before and during immune checkpoint inhibitor therapy
por: van de Donk, Pim P., et al.
Publicado: (2021) -
Preoperative BRAF inhibition in patients with irresectable locally advanced stage III melanoma
por: Faut, Marloes, et al.
Publicado: (2018) -
Clinical utility of circulating tumor DNA as a response and follow-up marker in cancer therapy
por: Boonstra, Pieter A., et al.
Publicado: (2020)